Back to Search
JEFFREY MERLIN, M.D.
M.D.
Emergency Medicine Physician
NPI: 1174812085IndividualAccepts Medicare
Education
LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Class of 2010
Research & Publications (20)
P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximab.
PMID 19165235·Cancer Gene Ther·2009
8-other
Rehabilitation of irradiated head and neck tissues by autologous fat transplantation.
PMID 19337087·Plast Reconstr Surg·2009
8-other
Validation of a phosphoprotein array assay for characterization of human tyrosine kinase receptor downstream signaling in breast cancer.
PMID 19443568·Clin Chem·2009
4-observational
PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
PMID 19212633·Oncol Rep·2009
8-other
Damaged DNA binding protein 2 plays a role in breast cancer cell growth.
PMID 18431487·PLoS One·2008
8-other
[Molecular diagnosis and response prediction to anti-tyrosine kinase receptors in oncology].
PMID 17489070·Ann Pharm Fr·2007
6-review
Topotecan can compensate for protracted radiation treatment time effects in high grade glioma xenografts.
PMID 16311843·J Neurooncol·2006
7-preclinical
Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.
PMID 16564229·Mol Ther·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13111 N PORT WASHINGTON RD
MEQUON, WI 53097 - Phone
- (414) 290-6720
Quick Facts
- NPI
- 1174812085
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile